EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vascular nitric oxide resistance in type 2 diabetes

Zahra Bahadoran, Parvin Mirmiran, Khosrow Kashfi, Asghar Ghasemi iD

Cell Death & Disease · 11.07.2023 · 14 (7)

DOI: 10.1038/s41419-023-05935-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Death & Disease, online erschienen am 11.07.2023. Verfasst von Zahra Bahadoran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Nitric Oxide, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular nitric oxide (NO•) resistance, manifested by an impaired vasodilator function of NO• in both the macro- and microvessels, is a common state in type 2 diabetes (T2D) associated with developing cardiovascular events and death. Here, we summarize experimental and human evidence of vascular NO• resistance in T2D and discuss its underlying mechanisms. Human studies indicate a ~ 13-94% decrease in the endothelium (ET)-dependent vascular smooth muscle (VSM) relaxation and a 6-42% reduced response to NO• donors, i.e., sodium nitroprusside (SNP) and glyceryl trinitrate (GTN), in patients with T2D. A decreased vascular NO• production, NO• inactivation, and impaired responsiveness of VSM to NO• [occurred due to quenching NO• activity, desensitization of its receptor soluble guanylate cyclase (sGC), and/or impairment of its downstream pathway, cyclic guanosine monophosphate (cGMP)-protein kinase G (PKG)] are the known mechanisms underlying the vascular NO• resistance in T2D. Hyperglycemia-induced overproduction of reactive oxygen species (ROS) and vascular insulin resistance are key players in this state. Therefore, upregulating vascular NO• availability, re-sensitizing or bypassing the non-responsive pathways to NO•, and targeting key vascular sources of ROS production may be clinically relevant pharmacological approaches to circumvent T2D-induced vascular NO• resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nitric OxideDiabetes Mellitus, Type 2HumansReactive Oxygen SpeciesNitric Oxide DonorsCyclic GMP

Substanzen

Nitric OxideReactive Oxygen SpeciesNitric Oxide DonorsCyclic GMP

Autor:innen und Institutionen

  • Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Clinical Nutrition, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Molecular, Cellular, and Biomedical Sciences, Sophie Davis School of Biomedical Education, City University of New York School of Medicine, New York, NY, 10031, USA.
  • Endocrine Physiology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Ghasemi@endocrine.ac.ir.

ORCID-Profile: Asghar Ghasemi

Zitieren

APA

Bahadoran, Z., Mirmiran, P., Kashfi, K., & Ghasemi, A. (2023). Vascular nitric oxide resistance in type 2 diabetes. Cell Death & Disease, 14(7). https://doi.org/10.1038/s41419-023-05935-5

Vancouver

Bahadoran Z, Mirmiran P, Kashfi K, Ghasemi A. Vascular nitric oxide resistance in type 2 diabetes. Cell Death & Disease. 2023;14(7). doi:10.1038/s41419-023-05935-5

BibTeX
@article{Bahadoran2023,
  author = {Bahadoran, Zahra and Mirmiran, Parvin and Kashfi, Khosrow and Ghasemi, Asghar},
  title = {Vascular nitric oxide resistance in type 2 diabetes},
  journal = {Cell Death & Disease},
  year = {2023},
  volume = {14},
  number = {7},
  doi = {10.1038/s41419-023-05935-5}
}
Kostenlos starten →